One-Pot Synthesis of Novel Hydrazono-1,3-Thiazohdin-4-One Derivatives as Anti-HIV and Anti-Tubercular Agents: Synthesis, Biological Evaluation, Molecular Modelling and Admet Studies

被引:6
作者
Pasha, Mohammad Arif [1 ]
Mondal, Sumanta [2 ]
Panigrahi, Naresh [2 ]
Shetye, Gauri [3 ]
Ma, Rui [3 ]
Franzblau, Scott G. [3 ]
Zheng, Yong-Tang [4 ]
Murugesan, Sankaranarayanan [5 ]
机构
[1] KR Mangalam Univ, Sch Med & Allied Sci, Dept Pharmaceut Chem, Sohna Rd, Sohna Rural 122103, Haryana, India
[2] GITAM Deemed Univ, GITAM Inst Pharm, Dept Pharmaceut Chem, Visakhapatnam 530045, Andhra Pradesh, India
[3] Univ Illinois, Coll Pharm, Inst TB Res, 833 South Wood St, Chicago, IL 60612 USA
[4] Chinese Acad Sci, Key Lab Bioact Peptides Yunnan Prov, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Yunnan, Peoples R China
[5] Birla Inst Technol & Sci, Dept Pharm, Med Chem Res Lab, Pilani 333031, Rajasthan, India
关键词
Hydrazono 1,3-thiazolidin-4-one; H(37)Rv; anti-HIV; anti-tubercular; ADMET; IN-VITRO; DESIGN; ANTICONVULSANT; INHIBITORS; ANALOGS;
D O I
10.2174/1570162X20666220512163049
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: The necessity for newer anti-HIV and anti-tubercular medications has arisen as a result of the prevalence of opportunistic infections caused by HIV (human immunodeficiency virus). Objective: A series of ten new hydrazono 1.3-thiazolidin-4-one derivatives were synthesized in one-pot and evaluated for anti-HIV and anti-tubercular activities. Molecular Docking was accomplished with HIV-1 reverse transcriptase protein (PDB ID: 1REV) and Mycobacterium Tuberculosis (M tuberculosis) H(37)Rv protein (PDB ID: 2YES) receptors along with drug-likeness and ADMET properties. Methods: One-pot synthesis of hydrazono 1,3-thiazolidin-4-one derivatives was carried out by ketones, thiosemicarbazide and ethylchloroacetate with the catalyst of anhydrous sodium acetate. All the synthesized compounds were characterized and evaluated for their in-vitro anti-HIV and also evaluated for their in-vitro anti-tubercular activity against M tuberculosis H(37)Rv. In-silico predicted physicochemical parameters were done by MedChem Designer (TM) software version 5.5 and ADMET parameters by pkCSM online tool. Furthermore, molecular docking was performed with pyrx 0.8 by autodock vina software. Results: All the synthesized compounds were characterized and evaluated for their in-vitro antiIlly activity for inhibition of syncytia formation, which shows KTE1 with EC50 47.95 mu M and Selectivity Index (SI) of >4.17 and for inhibition of p24 antigen production EC50 was found to be 80.02 mu M and SI of >2.49. The compounds were also evaluated for their in-vitro anti-tubercular activity against M tuberculosis H(37)Rv, in which KTE1 MIC values of 12.5 mu g/ml with SI of >4.0 and cytotoxicity against Vero cell lines. In-silico predicted physicochemical parameters for synthesized compounds which were found to be drug-like. Furthermore, docking has shown a good dock score and binding energy with anti-HIV and anti-tubercular receptors. Conclusion: From the novel synthesized molecules, none of the molecule is as effective as standards for anti-HIV and anti-tubercular drugs and hence can be further explored for its potential activities. Furthermore, derivatization was made to achieve more potent compounds for anti-HIV and anti-tubercular drugs.
引用
收藏
页码:255 / 271
页数:17
相关论文
共 39 条
[1]   Synthesis of new thiazolo-celecoxib analogues as dual cyclooxygenase-2/15-lipoxygenase inhibitors: Determination of regio-specific different pyrazole cyclization by 2D NMR [J].
Abdelall, Eman K. A. ;
Kamel, Gehan M. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 118 :250-258
[2]   Synthesis and anticonvulsant activity of some potential thiazolidinonyl 2-oxo/thiobarbituric acids [J].
Agarwal, A. ;
Lata, S. ;
Saxena, K. K. ;
Srivastava, V. K. ;
Kumar, A. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2006, 41 (10) :1223-1229
[3]  
[Anonymous], 2012, Wkly Epidemiol Rec, V87, P1
[4]   Design, Synthesis, and Biological Evaluation of 1-(thiophen-2-yl)-9H-pyrido[3,4-b]indole Derivatives as Anti-HIV-1 Agents [J].
Ashok, Penta ;
Lu, Cui-Lin ;
Chander, Subhash ;
Zheng, Yong-Tang ;
Murugesan, Sankarnarayanan .
CHEMICAL BIOLOGY & DRUG DESIGN, 2015, 85 (06) :722-728
[5]   Synthesis of new substituted azetidinoyl and thiazolidinoyl-1,3,4-thiadiazino (6,5-b) indoles as promising anti-inflammatory agents [J].
Bhati, Sudhir Kumar ;
Kumar, Ashok .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2008, 43 (11) :2323-2330
[6]   1,3-Dicarbonyl compounds in stereoselective domino and multicomponent reactions [J].
Bonne, Damien ;
Coquerel, Yoann ;
Constantieux, Thierry ;
Rodriguez, Jean .
TETRAHEDRON-ASYMMETRY, 2010, 21 (9-10) :1085-1109
[7]   Design, synthesis and in-vitro evaluation of novel tetrahydroquinoline carbamates as HIV-1 RT inhibitor and their antifungal activity [J].
Chander, Subhash ;
Ashok, Penta ;
Zheng, Yong-Tang ;
Wang, Ping ;
Raja, Krishnamohan S. ;
Taneja, Akash ;
Murugesan, Sankaranarayanan .
BIOORGANIC CHEMISTRY, 2016, 64 :66-73
[8]   Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis [J].
Cho, Sang Hyun ;
Warit, Saradee ;
Wan, Baojie ;
Hwang, Chang Hwa ;
Pauli, Guido F. ;
Franzblau, Scott G. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (04) :1380-1385
[9]  
Dallakyan S, 2015, METHODS MOL BIOL, V1263, P243, DOI 10.1007/978-1-4939-2269-7_19
[10]   Synthesis of 2-(aryl)-5-(arylidene)-4-thiazolidinone derivatives with potential analgesic and anti-inflammatory activity [J].
Deep, Aakash ;
Jain, Sandeep ;
Sharma, Prabodh Chander ;
Phogat, Priyanka ;
Malhotra, Manav .
MEDICINAL CHEMISTRY RESEARCH, 2012, 21 (08) :1652-1659